Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Contrast-Enhanced Spectral Mammography (CESM) in the Diagnostic Process of Breast Cancer

NCT06311695 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT06311695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06311695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Contrast-Enhanced Spectral Mammography (CESM) in the Diagnostic Process of Breast Cancer
Lead sponsor
European Institute of Oncology
Phase
Phase 2
Overall status
Unknown status
Start date
November 16, 2020
Completion date
December 31, 2025
Enrollment
263 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer